Tereshchenko S N, Kobalova Zh D, Demidova I V, Moiseev V S
Ter Arkh. 1997;69(12):40-3.
The 24-h profile of blood pressure (BP) was studied in 28 patients (21 males and 7 females) with congenital heart failure (CHF) of NYHA class II-III (ejection fraction < 45%). The patients were 46 to 76 years of age and had postinfarction cardiosclerosis. They had not received ACE inhibitors before. Two groups were formed basing on the presence of hypertension. Perindopril was administered in a single daily dose of 2 mg or higher if demanded to reduce symptoms of CHF and/or to normalize BP. The treatment continued for 3 months. The 24-h BP profile was assessed using portable device SpaceLabs 90207 (USA). In CHF patients with hypertension perindopril significantly lowered mean 24-h, day and night BP and its loads, reestablished two-phase circadian rhythm of AP and corrected BP variability. In CHF patients free of hypertension significant changes of the profile were not registered. It is evident that unwanted changes in the BP 24-h profile due to perindopril were absent in CHF normotensives.
对28例(21例男性和7例女性)纽约心脏协会(NYHA)心功能II - III级(射血分数<45%)的先天性心力衰竭(CHF)患者进行了24小时血压(BP)监测。患者年龄在46至76岁之间,患有心肌梗死后的心硬化。他们之前未接受过血管紧张素转换酶(ACE)抑制剂治疗。根据是否存在高血压将患者分为两组。培哚普利以每日2毫克或更高剂量(根据需要)给药,以减轻CHF症状和/或使血压正常化。治疗持续3个月。使用便携式设备SpaceLabs 90207(美国)评估24小时血压情况。在患有高血压的CHF患者中,培哚普利显著降低了24小时平均血压、日间和夜间血压及其负荷,恢复了血压的两阶段昼夜节律,并纠正了血压变异性。在无高血压的CHF患者中,未记录到血压情况的显著变化。显然,培哚普利不会使血压正常的CHF患者出现24小时血压情况的不良变化。